85 related articles for article (PubMed ID: 14654942)
21. Effects of MEK inhibitor U0126 on meiotic progression in mouse oocytes: microtuble organization, asymmetric division and metaphase II arrest.
Tong C; Fan HY; Chen DY; Song XF; Schatten H; Sun QY
Cell Res; 2003 Oct; 13(5):375-83. PubMed ID: 14672561
[TBL] [Abstract][Full Text] [Related]
22. Significant anti-proliferation of human endometrial cancer cells by combined treatment with a selective COX-2 inhibitor NS398 and specific MEK inhibitor U0126.
Gao J; Niwa K; Takemura M; Sun W; Onogi K; Wu Y; Seishima M; Mori H; Tamaya T
Int J Oncol; 2005 Mar; 26(3):737-44. PubMed ID: 15703831
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the invasion-metastasis mechanism in pancreatic cancer: involvement of plasmin(ogen) cascade proteins in the invasion of pancreatic cancer cells.
Tan X; Egami H; Nozawa F; Abe M; Baba H
Int J Oncol; 2006 Feb; 28(2):369-74. PubMed ID: 16391791
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylation regulates Myc expression via prolonged activation of the mitogen-activated protein kinase pathway.
Wang Z; Ge L; Wang M; Carr BI
J Cell Physiol; 2006 Jul; 208(1):133-40. PubMed ID: 16596619
[TBL] [Abstract][Full Text] [Related]
25. Role of mitogen-activated protein kinase kinase in Porphyromonas gingivalis-induced myocardial cell hypertrophy and apoptosis.
Lee SD; Chang SH; Kuo WH; Ying TH; Kuo WW; Li PC; Hsu HH; Lu MC; Ting H; Huang CY
Eur J Oral Sci; 2006 Apr; 114(2):154-9. PubMed ID: 16630308
[TBL] [Abstract][Full Text] [Related]
26. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
[TBL] [Abstract][Full Text] [Related]
27. Involvement of the expression and redistribution of claudin-23 in pancreatic cancer cell dissociation.
Wang W; Tan X; Zhou L; Gao F; Dai X
Mol Med Rep; 2010; 3(5):845-50. PubMed ID: 21472324
[TBL] [Abstract][Full Text] [Related]
28. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
Bessard A; Frémin C; Ezan F; Coutant A; Baffet G
J Cell Physiol; 2007 Aug; 212(2):526-36. PubMed ID: 17427199
[TBL] [Abstract][Full Text] [Related]
29. Expression of nerve growth factor and tyrosine kinase receptor A and correlation with perineural invasion in pancreatic cancer.
Ma J; Jiang Y; Jiang Y; Sun Y; Zhao X
J Gastroenterol Hepatol; 2008 Dec; 23(12):1852-9. PubMed ID: 19120874
[TBL] [Abstract][Full Text] [Related]
30. MUC5AC mucin gene regulation in pancreatic cancer cells.
Kato S; Hokari R; Crawley S; Gum J; Ahn DH; Kim JW; Kwon SW; Miura S; Basbaum CB; Kim YS
Int J Oncol; 2006 Jul; 29(1):33-40. PubMed ID: 16773182
[TBL] [Abstract][Full Text] [Related]
31. Ras/MEK pathway is required for NGF-induced expression of tyrosine hydroxylase gene.
Suzuki T; Kurahashi H; Ichinose H
Biochem Biophys Res Commun; 2004 Mar; 315(2):389-96. PubMed ID: 14766220
[TBL] [Abstract][Full Text] [Related]
32. Ribonucleotide reductase small subunit p53R2 suppresses MEK-ERK activity by binding to ERK kinase 2.
Piao C; Jin M; Kim HB; Lee SM; Amatya PN; Hyun JW; Chang IY; You HJ
Oncogene; 2009 May; 28(21):2173-84. PubMed ID: 19398949
[TBL] [Abstract][Full Text] [Related]
33. A MEK inhibitor (U0126) prolongs survival in nude mice bearing human gallbladder cancer cells with K-ras mutation: analysis in a novel orthotopic inoculation model.
Horiuchi H; Kawamata H; Fujimori T; Kuroda Y
Int J Oncol; 2003 Oct; 23(4):957-63. PubMed ID: 12963974
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological targeting of the constitutively activated MEK/MAPK-dependent signaling pathway in glioma cells inhibits cell proliferation and migration.
Glassmann A; Reichmann K; Scheffler B; Glas M; Veit N; Probstmeier R
Int J Oncol; 2011 Dec; 39(6):1567-75. PubMed ID: 21850371
[TBL] [Abstract][Full Text] [Related]
35. MEK inhibition of pancreatic carcinoma cells by U0126 and its effect in combination with sulindac.
Yip-Schneider MT; Schmidt CM
Pancreas; 2003 Nov; 27(4):337-44. PubMed ID: 14576498
[TBL] [Abstract][Full Text] [Related]
36. Signal transduction pathway of the induction of cell motility in hamster pancreatic ductal adenocarcinoma cell.
Akagi J; Egami H; Kurizaki T; Ohmachi H; Ogawa M
Invasion Metastasis; 1997; 17(1):16-25. PubMed ID: 9425321
[TBL] [Abstract][Full Text] [Related]
37. Basic fibroblast growth factor induces the expression of matrix metalloproteinase-3 in human periodontal ligament cells through the MEK2 mitogen-activated protein kinase pathway.
Shimazu A; Morishita M
J Periodontal Res; 2003 Apr; 38(2):122-9. PubMed ID: 12608905
[TBL] [Abstract][Full Text] [Related]
38. MicroRNAs associated with mitogen-activated protein kinase in human pancreatic cancer.
Ikeda Y; Tanji E; Makino N; Kawata S; Furukawa T
Mol Cancer Res; 2012 Feb; 10(2):259-69. PubMed ID: 22188669
[TBL] [Abstract][Full Text] [Related]
39. Interaction of tRNA with MEK2 in pancreatic cancer cells.
Wang X; Chow CR; Ebine K; Lee J; Rosner MR; Pan T; Munshi HG
Sci Rep; 2016 Jun; 6():28260. PubMed ID: 27301426
[TBL] [Abstract][Full Text] [Related]
40. MEK1 and MEK2 isoforms regulate distinct functions in pancreatic cancer cells.
Zhou L; Tan X; Kamohara H; Wang W; Wang B; Liu J; Egami H; Baba H; Dai X
Oncol Rep; 2010 Jul; 24(1):251-5. PubMed ID: 20514469
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
